KCNQ2 variants determine severity of neonatal onset epilepsyKCNQ2 variants determine severity of neonatal onset epilepsy
KCNQ2 developmental epileptic encephalopathy
Dr. Millichap discloses the following relationships:
Consultant: Xenon, Ionis, and Eisai.
Speakers bureau: BioMarin, Greenwich, Sunovion, and Mallinckrodt.
Grant support: NIH, Citizens United for Research in Epilepsy, UCB, Disruptive Nutrition, and Xenon.
Editorial honoraria: AAN and UpToDate